Seoul National University Bundang Hospital
Gyeongg-ido, South Korea
NCT Number: NCT01715597
The investigators want to know whether the intravenous ascorbic acid would reduce the blood loss during laparoscopic myoma surgery. The investigators randomized patients into intravenous ascorbic acid group and placebo group and examined the blood loss in both groups.
Looking for future studies?
Notify MeFemale
Interventional
Phase 3
Gyeongg-ido, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour
normal saline 500ml IV
Time frame: during laparoscopic myomectomy
Time frame: during laparoscopic myomectomy
Time frame: during laparoscopic myomectomy
Time frame: postoperative day 1
postoperative day 1 hemoglobin - preoperative hemoglobin + hemoglobin increased by transfusion (hemoglobin 1 per RBC 1 pack transfusion)
Time frame: 2days after the operation
Seoul National University Hospital
Other
Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06959966
Connective Tissue Diseases, Myofibroma
Taipei, Xinyi, Taiwan
View Trial DetailsNCT06115408
Connective Tissue Diseases, Myofibroma
Cairo, Egypt
View Trial DetailsNCT03751124
Connective Tissue Diseases, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04874246
Connective Tissue Diseases, Diabetes Insipidus
Seoul, South Korea
View Trial Details